Open AccessAllergen immunotherapy for allergic asthma: protocol for a systematic review
Author(s) -
Dhami Sangeeta,
Nurmatov Ulugbek,
Agache Ioana,
Lau Susanne,
Muraro Antonella,
Jutel Marek,
Roberts Graham,
Akdis Cezmi,
Bonini Matteo,
Calderon Moises,
Casale Thomas,
Cavkaytar Ozlem,
Cox Linda,
Demoly Pascal,
Flood Breda,
Hamelmann Eckard,
Izuhara Kenji,
Kalayci Ömer,
KleineTebbe Jörg,
Nieto Antonio,
Papadopoulos Nikolaos,
Pfaar Oliver,
Rosenwasser Lanny,
Ryan Dermot,
SchmidtWeber Carsten,
Szefler Stan,
Wahn Ulrich,
Wijk RoyGerth,
Wilkinson Jamie,
Sheikh Aziz
Publication year - 2016
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/s13601-016-0094-y
Subject(s) - medicine , asthma , allergen immunotherapy , allergy , clinical immunology , protocol (science) , alternative medicine , allergic asthma , immunology , intensive care medicine , allergen , family medicine , pathology
Background The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost‐effectiveness and safety of AIT in the management of allergic asthma. Methods We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre‐defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. Discussion The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.